NEW YORK, Jan. 17, 2018 /PRNewswire/ -- CareDox, a pediatric healthcare technology leader, today announced it has closed a Series B financing of $16 million, co-led by AI Life Sciences Investments LLC and 7wire Ventures with additional investments from Digitalis, Prolog Ventures, StartUp Health, and Wanxiang Healthcare Investments.
"K through 12 schools manage healthcare for more than 50 million kids nationwide, making them the largest healthcare delivery system in this country. Yet, they are highly fragmented and disconnected from traditional care settings. We have a huge opportunity and responsibility to improve pediatric care by digitally connecting the real care team – school nurses, parents, pediatricians – around the child, wherever they are," said Hesky Kutscher, CEO, CareDox. "We are thrilled that our investor syndicate shares our vision to radically improve pediatric health through technology that better serves and connects students, parents, providers and payers."
CareDox is enabling a new kind of pediatric care delivery system by providing healthcare technology to K-12 public schools, bridging the gap between schools, parents and medical professionals. The company's secure, HIPAA and FERPA-compliant platform captures student medical charts, medications and immunizations, and engages parents and providers with alerts about health events.
CareDox currently serves more than 2 million children through its work with more than 4,000 schools and several, large healthcare payers nationwide.
Most recently, CareDox partnered with HealthySchools, a Florida-based public-private partnership that seeks to promote pediatric health by administering influenza vaccines at partnered schools. HealthySchools is leveraging CareDox technology to manage the digital workflow associated with its vaccine and well care visit program for underserved children.
"36 million American children, a majority of the country's school age population, are covered by Medicaid or another form of public health. In many cases, however, their health needs are not being met," said Avi Naider, manager of AI Life Sciences Investments LLC, an Access Industries affiliate. "The services provided by CareDox make sense; go where the kids are – schools. By connecting schools, parents and providers through the CareDox platform we can improve student healthcare outcomes. We are proud to participate in this financing and facilitate CareDox's mission to materially improve the quality of pediatric health in America."
"CareDox is making care coordination work for children and families in a way that's never been done before; by connecting schools with providers through healthcare technology, care delivery doesn't have to stop or start depending on where the child goes. We're excited to see this platform scale and improve health outcomes for children nationwide," said Robert Garber, Partner, 7wire Ventures.
For more information on CareDox, please visit www.caredox.com.
CareDox is the leader in pediatric healthcare technology aimed at transforming the most consistent health delivery system in the U.S.; K-12 public schools. The company currently connects its cloud-based, digital health to immunization registries in 38 states, and its free medical technology covers students in more than 4,000 schools. The company was founded in 2014 and is based in New York City. To learn more about CareDox and how they work with schools, providers and payers to ensure continuity of care and prevent widespread illness at school and beyond, please visit www.caredox.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/caredox-secures-16-million-in-series-b-financing-to-transform-pediatric-health-300583666.html